Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of macitentan 10 mg tablets in healthy Thai volunteers
TCTR20221001005Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of macitentan (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 1 more. Started Dec 2022; status: completed.
02
Drugs
macitentan
Beyond the preview
Go deeper on TCTR20221001005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221001005.